Ascendis Announces Planned $400 Million Share Repurchase Program

COPENHAGEN, Denmark, Sept. 14, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to repurchase up to $400 million of the Company’s ordinary shares (the Share Repurchase Program).

Purchases under the planned Share Repurchase Program may be made from time to time, in such amounts as management deems appropriate, through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated share repurchase transactions, purchases through 10b5-1 trading plans, or by any combination of such methods. The timing and amount of any repurchases pursuant to the Share Repurchase Program will be determined based on market conditions, share price and other factors. The Share Repurchase Program does not require the Company to repurchase any specific number of shares, and may be modified, suspended or terminated at any time without notice.

About Ascendis Pharma A/S

Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.

Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Ascendis’ future operations, plans and objectives of management are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of such statements include, but are not limited to, statements relating to (i) the planned Share Repurchase Program, including the timing, amount, and methods of any repurchases, (ii) Ascendis’ ability to apply its TransCon technology platform to make a meaningful difference for patients and (iii) Ascendis’ use of TransCon to develop new and potentially best-in-class therapies to address unmet medical needs. Ascendis may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Ascendis makes, including, without limitation: dependence on third‑party manufacturers, distributors, and service providers for Ascendis’ products and product candidates; risks related to regulatory review and approval, including the possibility of delays, requests for additional data or analyses, restrictions or limitations on use, approval with labeling that is more limited than expected, or failure to obtain approval in the United States, European Union, or other jurisdictions; clinical development risks, including that results from ongoing or future trials may not confirm earlier data; unforeseen safety or efficacy findings in development programs or on‑market products; manufacturing, supply chain, quality, or logistics issues that could delay development or commercialization; unforeseen expenses related to commercialization of any approved Ascendis products; unforeseen research and development or selling, general and administrative expenses and other costs impacting Ascendis’ business generally; market acceptance, pricing, and reimbursement challenges, including payer coverage decisions and health technology assessments; competitive developments, including new or improved therapies; intellectual property protection, freedom‑to‑operate, and litigation risks; Ascendis’ ability to obtain additional funding, if needed, to support its business activities; cybersecurity, data privacy, and information technology disruptions; and the impact of international economic, political, legal, compliance, public health, and business factors, including tariffs, trade policies, currency fluctuations, and geopolitical events. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ascendis’ business in general, see Ascendis’ Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (SEC) on February 11, 2026, and Ascendis’ other future reports filed with, or submitted to, the SEC. Forward-looking statements do not reflect the potential impact of any future licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments that Ascendis may enter into or make. Ascendis does not assume any obligation to update any forward-looking statements, except as required by law.

Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, and TransCon

®

are trademarks owned by the Ascendis Pharma Group. © September 2026 Ascendis Pharma A/S.


Investor Contact:

Media Contact:
Chad Fugere Melinda Baker
Ascendis Pharma Ascendis Pharma
+1 (650) 519-7494 +1 (650) 709-8875



Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

All rights to TransCon technology-based products in metabolic and cardiovascular diseases, including once-monthly TransCon Semaglutide, will revert to Ascendis
Ascendis to initiate multiple programs in metabolic and cardiovascular diseases, including obesity

COPENHAGEN, Denmark, Sept. 14, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that it will regain the exclusive rights to develop, manufacture, and commercialize TransCon technology-based products in metabolic and cardiovascular diseases, including obesity. This follows termination of the collaboration agreement between Ascendis and Novo Nordisk A/S announced in November 2024. Under the terms of the agreement, following termination all licenses granted to Novo Nordisk in metabolic and cardiovascular diseases, including for once-monthly TransCon Semaglutide, will revert to Ascendis, and neither party has any continuing financial obligations to the other.

Upon effective termination and reversion of rights, Ascendis plans to initiate multiple programs in both rare and large metabolic and cardiovascular indications, where it believes it can establish best-in-class therapies. These new programs include advancing once-monthly TransCon Semaglutide, an investigational long-acting prodrug of the GLP-1 receptor agonist semaglutide, as a potential treatment for obesity and type 2 diabetes.

“Our mission is to always make a meaningful difference for patients and Ascendis now plans to initiate multiple new programs in cardiovascular and metabolic diseases, including obesity, focusing where the unmet medical needs are greatest,” said Jan Mikkelsen, Ascendis Pharma’s President and Chief Executive Officer. “Our algorithm for product innovation has delivered three consecutive approved products and we are excited to apply our versatile TransCon platform with the same disciplined approach across these therapeutic areas, consistent with Vision 2030.”

About Ascendis Pharma A/S

Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.

Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Ascendis’ future operations, plans and objectives of management are forward-looking statements. Examples of such statements include, but are not limited to, statements relating to (i) the expected timing and effectiveness of the termination of the collaboration agreement with Novo Nordisk A/S and the reversion of rights to Ascendis, (ii) Ascendis’ plans to initiate multiple programs in metabolic and cardiovascular diseases, including obesity, (iii) the expected development and commercialization of once-monthly TransCon Semaglutide as a potential treatment for obesity and type 2 diabetes, (iv) Ascendis’ ability to establish best-in-class therapies in rare and large metabolic and cardiovascular indications, (v) Ascendis’ ability to apply its TransCon platform technology consistent with Vision 2030, and (vi) Ascendis’ use of its TransCon technology platform to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Ascendis makes, including the following: unforeseen issues relating to the termination of the Novo Nordisk collaboration agreement, including potential disputes regarding the basis of termination or breach claims; dependence on third party manufacturers and distributors; unforeseen safety or efficacy results in TransCon Semaglutide or other development programs; unforeseen expenses related to development and potential commercialization of TransCon technology-based products in metabolic and cardiovascular diseases; delays in the development of TransCon Semaglutide or other development programs related to manufacturing, regulatory requirements, speed of patient recruitment or other unforeseen delays; and Ascendis’ ability to obtain additional funding, if needed, to support its business activities. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ascendis’ business in general, see Ascendis’ most recent Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (SEC) and Ascendis’ other future reports filed with, or submitted to, the SEC. Forward-looking statements do not reflect the potential impact of any future licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments that Ascendis may enter into or make. Ascendis does not assume any obligation to update any forward-looking statements, except as required by law.
Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, and TransCon®are trademarks owned by the Ascendis Pharma group. © September 2026 Ascendis Pharma A/S.


Investor Contacts:


Chad Fugere
Ascendis Pharma
+1 (650) 519-7494
 
Media Contact:


Melinda Baker
Ascendis Pharma
+1 (650) 709-8875



Western Alliance Bancorporation to Participate in Fireside Chat at Barclays Global Financial Services Conference

Western Alliance Bancorporation to Participate in Fireside Chat at Barclays Global Financial Services Conference

Chairman, President and CEO Ken Vecchione to participate in investor conference discussion on Sept. 16

PHOENIX–(BUSINESS WIRE)–
Western Alliance Bancorporation (NYSE: WAL) today announced that Chairman, President and Chief Executive Officer Ken Vecchione will participate in a fireside chat at the Barclays Global Financial Services Conference on Wednesday, September 16, 2026.

The fireside chat is scheduled to begin at 10:30 a.m. Eastern Time (7:30 a.m. Arizona time). A live audio webcast of the presentation will be available at investors.westernalliancebancorporation.com under Events & Presentations. A replay of the webcast will be available following the event.

About Western Alliance Bancorporation

Western Alliance Bancorporation (NYSE: WAL) is one of the country’s top-performing banking companies. Its primary subsidiary, Western Alliance Bank, Member FDIC, is a leading national bank for business that puts customers first, delivering tailored business banking solutions and consumer products backed by outstanding, personalized service and specific expertise in more than 30 industries and sectors. With more than $90 billion in assets and offices nationwide, Western Alliance has ranked as a top U.S. bank by American Banker and Bank Director since 2016. In 2025, Western Alliance Bancorporation was #2 for Best CEO, Best CFO and Best Company Board of Directors on Extel’s All-America Executive Team Mid-Cap Banks list. For more information on offerings, subsidiaries and affiliates, visit www.westernalliancebank.com or follow Western Alliance Bank on LinkedIn.

Media Contact:

Nicole Johnson, 602.661.6053

[email protected]

Investors:

Miles Pondelik, 602.346.7462

[email protected]

KEYWORDS: Arizona United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Marcus & Millichap Capital Corporation Arranges $53 Million Build-to-Rent Refinance in Northwest Arkansas

Marcus & Millichap Capital Corporation Arranges $53 Million Build-to-Rent Refinance in Northwest Arkansas

ROGERS, Ark.–(BUSINESS WIRE)–Marcus & Millichap Capital Corporation (MMCC), a leading provider of commercial real estate capital markets financing solutions, has arranged $53 million in refinancing for The Grove, a build-to-rent (BTR) multifamily property in Rogers, Arkansas.

John Brickson, managing director in MMCC’s Dallas office, represented a joint venture between Brittenum Group and Realty Capital Partners in securing and structuring three-year, nonrecourse financing.

“This financing repaid the borrower’s construction loan ahead of maturity, giving the borrower time to season the rent roll and position the property for a successful sale,” said Brickson. “The Grove has been very well received in the market and has exceptional resident demographics, with median household income of nearly $100,000 among the existing resident base. The property is one of the largest BTR communities by unit count in the Northwest Arkansas region and one of the few projects offering fully detached, single-family-style homes.”

Built in 2024, this 235-unit Class A community is 94.5% occupied and consists of 123 detached two-story, single-family-style cottages and 112 attached townhome-style residences. Amenities include a resort-style pool, 24-hour fitness center, golf simulator, package lockers, community clubhouse with co-working offices and a community kitchen, and a pickleball court.

About Marcus & Millichap Capital Corporation

Marcus & Millichap Capital Corporation (MMCC) is a subsidiary of Marcus & Millichap (NYSE: MMI), a leading commercial real estate investment services firm with offices throughout the United States and Canada. MMCC provides commercial real estate capital markets financing solutions, including debt, mezzanine financing, preferred and joint venture equity, sponsor equity, loan sales and consultative and due diligence services. In 2025, MMCC closed 1,659 transactions totaling $11.9 billion. To learn more, please visit: marcusmillichap.com/financing.

About Brittenum Group

The Brittenum Group is a privately held, fully integrated residential development and construction firm focused on the development of single family, townhome, and build-to-rent communities throughout Northwest Arkansas. Through its affiliated entities, including Brittenum Residential, Brittenum Construction, and Precision Sitework, the firm provides comprehensive in-house capabilities spanning development, construction management, sitework, and project delivery. The Brittenum Group has established a strong presence throughout the Northwest Arkansas market with communities located across Bentonville, Fayetteville, Rogers, Springdale, Prairie Grove, and surrounding submarkets. The firm is led by Chief Executive Officer Jon Brittenum Jr, an experienced developer with over 30 years of industry expertise across land development, construction, and strategic growth. For more information, please visit www.brittenumresidential.com

About Marcus & Millichap, Inc. (NYSE:MMI)

Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services, with offices throughout the United States and Canada. Marcus & Millichap closed 8,818 transactions with a sales volume of $50.8 billion in 2025. At year-end, the company had 1,808 investment sales and financing professionals in more than 80 offices providing investment brokerage and financing services to commercial real estate sellers and buyers. For additional information, visit www.MarcusMillichap.com.

Gina Relva, VP of Public Relations
[email protected]

KEYWORDS: Arkansas Texas United States North America

INDUSTRY KEYWORDS: Professional Services Residential Building & Real Estate Commercial Building & Real Estate Finance Construction & Property Asset Management REIT

MEDIA:

Logo
Logo

TWO Announces Intention to Voluntarily Delist and Deregister 9.375% Senior Notes due 2030 from the New York Stock Exchange

TWO Announces Intention to Voluntarily Delist and Deregister 9.375% Senior Notes due 2030 from the New York Stock Exchange

NEW YORK–(BUSINESS WIRE)–TWO (Two Harbors Investment Corp.), a wholly-owned subsidiary of CrossCountry Mortgage, LLC, today announced that it has notified the New York Stock Exchange (the “NYSE”) of its intention to voluntarily delist TWO’s 9.375% Senior Notes due 2030 (NYSE: TWOD) (the “Notes”) from the NYSE and to withdraw the Notes from registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). To delist and deregister the Notes, TWO expects to file a Form 25 with the U.S. Securities and Exchange Commission (the “SEC”) on or about September 24, 2026, which is no fewer than 10 days after the date on which TWO notified the NYSE of its intent to voluntarily delist the Notes.

In connection with the recently completed merger of TWO and CrossCountry Mortgage, LLC (the “Merger”), TWO satisfied and discharged its obligations under the indenture pursuant to which the Notes were issued (the “Discharge”). Concurrently with the satisfaction and discharge, CrossCountry Intermediate HoldCo, LLC commenced an offer (the “Offer”) to repurchase all outstanding Notes at $26.3841 per Note, equal to 104% of the $25.00 principal amount, plus accrued and unpaid interest, if any, to, but excluding, October 14, 2026, and irrevocably deposited with U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), $123.1 million in funds, which is sufficient to pay the purchase price for all Notes tendered in the Offer and to fund all future interest payments and to redeem all Notes that remain outstanding following the Offer. To the extent all Notes are not repurchased in the Offer, such Notes will be redeemed on May 17, 2027 (the “Redemption Date”) at a redemption price equal to 100% of the principal amount thereof ($25.00 per Note), plus accrued and unpaid interest, if any, to, but excluding, the Redemption Date (the “Redemption Price”), after which no Notes are expected to be outstanding.

TWO’s decision to delist and deregister the Notes reflects its determination that, as a result of the Merger and the Discharge, the company is no longer required to maintain the NYSE listing and SEC registration. TWO has complied with all applicable state and federal securities laws in connection with the proposed delisting and deregistration of the Notes.

The delisting is expected to become effective 10 days after the Form 25 is filed, and the last day of trading for the Notes is expected to be October 2, 2026. Following the delisting of the Notes from the NYSE, TWO intends to take such actions as may be necessary to terminate or suspend its reporting obligations under the Exchange Act.

Notice of redemption will be mailed to holders of the Notes on or about April 16, 2027. Questions about the offer and related materials should be directed to U.S. Bank Trust Company, National Association, 111 Fillmore Avenue E, St. Paul, MN 55107 or by phone at 1-800-934-6802.

This press release does not constitute an offer to purchase or a notice of redemption under the indenture governing the Notes.

Cautionary Notice Regarding Forward-Looking Statements

This release may include statements and information that constitute “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended, and we intend such forward-looking statements to be covered by the safe harbor provisions therein and are included in this statement for purposes of invoking these safe harbor provisions. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, targets, expectations, anticipations, assumptions, estimates, intentions and future performance. The forward-looking statements made in this release include, but may not be limited to, expectations regarding the Offer, the redemption of Notes not tendered and the Discharge.

Forward-looking statements are not guarantees, and they involve risks, uncertainties and assumptions. There can be no assurance that actual results will not differ materially from our expectations. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks identified under the captions “Risk Factors,” “Forward-Looking Statements” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our public filings with the SEC, which are available on the SEC’s website at www.sec.gov.

All written or oral forward-looking statements that we make, or that are attributable to us, are expressly qualified by this cautionary notice. Except to the extent required by applicable laws and regulations, we undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.

About TWO

TWO, a Maryland corporation, is a wholly owned subsidiary of CrossCountry Mortgage, LLC that invests in mortgage servicing rights, residential mortgage-backed securities and other financial assets. TWO is headquartered in St. Louis Park, Minnesota.

About CCM

CrossCountry Mortgage (CCM) is the nation’s largest distributed retail mortgage lender and sixth-largest non-bank servicer, with more than 9,800 employees operating over 1,100 branches and servicing loans across all 50 states, D.C. and Puerto Rico. Our company has been recognized ten times on the Inc. 5000 list of America’s fastest-growing private businesses and has received numerous awards for its standout culture. We offer more than 120 mortgage, refinance and home equity solutions — ranging from conventional and jumbo mortgages to government-insured programs from the FHA and programs for Veterans and rural homebuyers — and we are a direct lender and approved seller and servicer for Freddie Mac, Fannie Mae and Ginnie Mae. NMLS #3029. Through our dedication to getting it done, we make every mortgage feel like a win.

CCM Investor Relations

[email protected]

KEYWORDS: United States North America Maryland New York Minnesota

INDUSTRY KEYWORDS: Other Professional Services Construction & Property Finance Banking Professional Services REIT Other Construction & Property Residential Building & Real Estate

MEDIA:

Logo
Logo

Rithm Capital, GreenBarn Investment Group and FarmViewVentures Announce $56.25 Million Sale of 4075 Wilson Boulevard in Arlington, Virginia

Rithm Capital, GreenBarn Investment Group and FarmViewVentures Announce $56.25 Million Sale of 4075 Wilson Boulevard in Arlington, Virginia

Sale to Piedmont Realty Trust follows successful repositioning, more than 90,000 square feet of new leasing and $6 million in strategic capital improvements

ARLINGTON, Va.–(BUSINESS WIRE)–
Rithm Capital Corp. (“Rithm”), GreenBarn Investment Group (“GreenBarn”) and FarmViewVentures (“FarmView”) today announced the $56.25 million sale of 4075 Wilson Boulevard, a 188,014-square-foot Class A office property in Arlington’s Ballston submarket, to Piedmont Realty Trust, Inc.

The sale marks the culmination of a successful repositioning strategy undertaken by Rithm, GreenBarn and FarmView since acquiring the property in September 2024. During their ownership, the group completed more than 90,000 square feet of new leasing and invested more than $6 million in strategic capital improvements designed to enhance the tenant experience and strengthen the property’s position within one of Northern Virginia’s most dynamic office markets.

“We had conviction in Ballston when we acquired 4075 Wilson Boulevard in 2024 because we believed the market’s underlying dynamics were stronger than many investors recognized at the time,” said John Wolf, Founder and Managing Partner of FarmViewVentures. “Through our local knowledge and relationships, we saw the return-to-office trend taking hold, a compelling mixed-use environment and a defense and technology ecosystem anchored by organizations like DARPA that we believed would continue to benefit from increased defense and cybersecurity spending. As investors, our job is to find opportunities where the market may not yet fully appreciate the nuances of a particular location. We believed Ballston was one of those opportunities, and 12 to 18 months later, many of the trends we identified are becoming much more broadly recognized.”

“Our diligence on the Ballston submarket, combined with a disciplined underwriting approach, was central to how this deal came together,” said Jonny Nierenberg, Vice President, Investment Strategy – Commercial Real Estate at Rithm Capital. “The successful execution of our business plan reflects both the strength of our partnership with GreenBarn and FarmView and the type of compelling, well-located opportunities we continue to pursue across commercial real estate.”

The property’s tenant roster includes Nalej Corporation, KnowBe4, Systems Planning & Analysis and OpenText Public Sector, among other government contractors, technology companies and professional services firms. Ground-floor retail is fully leased to tenants including Sweetgreen, Grazie Nonna, Van Leeuwen Ice Cream and Pinnacle Bank.

Capital improvements completed during Rithm, GreenBarn and FarmView’s ownership include a new tenant amenity center as well as an upgraded lobby and renovated rooftop terrace. Located at Wilson Boulevard and North Randolph Street, the property sits across from Ballston Quarter and near the Ballston Metro station, within one of Northern Virginia’s most established defense and technology corridors.

Newmark Capital Markets Executive Managing Directors Jud Ryan and James P. Cassidy, along with Vice President Grant Marley, represented Rithm, GreenBarn and FarmView in the transaction.

“4075 Wilson Boulevard represents the first round-trip office investment during the current office cycle thanks to ownership’s successful repositioning strategy in one of our region’s most vibrant submarkets,” said Jud Ryan, Executive Managing Director at Newmark. “The transaction reflects continued investor demand for well-positioned assets with durable tenant rosters and compelling long-term fundamentals.”

About Rithm Capital Corp.

Rithm Capital Corp. is a global alternative asset manager with significant experience managing credit and real estate assets. Rithm’s integrated platform spans asset-based finance, residential and commercial real estate lending, mortgage servicing rights, and structured credit. Through platforms including Elecor Properties, Newrez, Genesis Capital, Sculptor Capital Management, and Crestline Management, Rithm employs a unique owner-operator model to drive value for shareholders and investors. For more information, visit www.rithmcap.com.

About GreenBarn Investment Group

GreenBarn Investment Group is a vertically integrated investment management firm that utilizes its extensive network and industry experience to acquire and develop real estate assets, make and invest in real estate loans, and invest in commercial real estate credit special situations.

About FarmViewVentures

FarmViewVentures is a real estate investment firm focused on identifying and executing compelling investment opportunities across the commercial real estate sector. Led by Founder and Managing Partner John Wolf, the firm brings extensive experience investing in, owning and operating institutional-quality real estate assets.

Media contact:

For Rithm:

Jonathan Gasthalter/Sam Cohen

Gasthalter & Co.

212-257-4170

[email protected]

For GreenBarn Investment Group:

Scott Cianciulli

The Plunkett Group

[email protected]

KEYWORDS: United States North America Virginia

INDUSTRY KEYWORDS: Finance Professional Services Commercial Building & Real Estate Asset Management Construction & Property

MEDIA:

Logo
Logo

Home Bancshares, Inc. Announces Third Quarter Earnings Release Date And Conference Call

CONWAY, Ark., Sept. 14, 2026 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB), parent company of Centennial Bank, today announced it expects to release Third Quarter 2026 earnings after the market closes on October 14, 2026. Following this release, management will conduct a conference call to review these earnings at 1:00 p.m. CT (2:00 p.m. ET) on Thursday, October 15, 2026.

We strongly encourage all participants to pre-register for the conference call webcast or the live call using one of the following links. First, participants can pre-register for the conference call webcast using the following link:  https://events.q4inc.com/attendee/887189816. Participants who pre-register will be given a unique webcast link to gain immediate access to the conference call webcast. Second, participants can pre-register for the live call using the following link: https://events.q4inc.com/analyst/887189816?pwd=Khijd6H0. Participants who pre-register will be given the phone number and unique access codes to gain immediate access to the live call. Participants may pre-register now, or at any time prior to the call, and will immediately receive simple instructions via email. The Home BancShares conference call will also be scheduled as an event in your Outlook calendar.

Those without internet access or unable to pre-register may dial in and listen to the live call by calling 1-833-461-5787, Passcode: 887189816. A replay of the call will be available using the following link: https://events.q4inc.com/attendee/887189816. Internet access to the call will be available live or in recorded version on the Company’s website at www.homebancshares.com.

Home BancShares, Inc. is a bank holding company, headquartered in Conway, Arkansas. Its wholly-owned subsidiary, Centennial Bank, provides a broad range of commercial and retail banking plus related financial services to businesses, real estate developers, investors, individuals and municipalities. Centennial Bank has branch locations in Arkansas, Florida, Texas, Tennessee, South Alabama and New York City. The Company’s common stock is traded through the New York Stock Exchange under the symbol “HOMB.”

FOR MORE INFORMATION CONTACT:


Home BancShares, Inc.


Donna Townsell
Senior Executive Vice President &
Director of Investor Relations
(501) 328-4625
Ticker symbol: HOMB



Boxlight Regains Compliance with Nasdaq Listing Requirements

Boxlight Regains Compliance with Nasdaq Listing Requirements

DULUTH, Ga.–(BUSINESS WIRE)–Boxlight Corporation (Nasdaq: BOXL) (“Boxlight” or the “Company”), a leading provider of interactive technology solutions, today announced that it has regained compliance with Nasdaq for continued listing and that its stock will continue to trade on The Nasdaq Stock Market.

The Company announced that on September 2, 2026, it received a written decision (the “Panel Decision”) from the Nasdaq Hearings Panel (the “Panel”) determining that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity (the “Equity Rule”), and granting the Company’s request for continued listing on The Nasdaq Stock Market (“Nasdaq”). The Panel’s determination followed a hearing held on August 13, 2026, at which the Company presented its compliance plan, including the completion of a PIPE transaction yielding approximately $6.6 million in net proceeds (the “Series D Convertible Preferred Stock Financing”), an anticipated $15 million equity line of credit, and a planned $2.9 million debt-to-equity swap. On August 5, 2026, the Company closed the Tranche One of the Series D Convertible Preferred Stock Financing, raising $4.8 million, net of fees.

Pursuant to Nasdaq Listing Rule 5815(d)(4)(A), the Panel imposed a one-year Discretionary Panel Monitor on the Company, effective August 17, 2026 (the “Monitoring Period”). During the Monitoring Period, if the Listing Qualifications Staff finds the Company out of compliance with any Nasdaq Listing Rule, notwithstanding Rule 5810(c)(2), the Company will not be permitted to provide a compliance plan, Staff will not be permitted to grant additional time for the Company to regain compliance, and the Company will not be afforded an applicable cure or compliance period pursuant to Rule 5810(c)(3). Instead, Staff will issue a Delist Determination Letter, at which time the Company may request a new hearing before the Panel or a newly convened Hearings Panel, and the Company’s securities may be delisted from Nasdaq.

The Company may request review of the Panel Decision by the Nasdaq Listing and Hearing Review Council. A written request for review must be received within 15 calendar days from the date of the Panel Decision, subject to a $15,000 fee. Additionally, the Nasdaq Listing and Hearing Review Council may, on its own motion, determine to review the Panel Decision within 45 calendar days after issuance of the written decision.

About Boxlight Corporation

Boxlight Corporation (Nasdaq: BOXL) is a leading provider of interactive technology solutions under its award-winning brands Clevertouch®, FrontRow™ and Mimio®. Boxlight aims to improve engagement and communication in diverse business and education environments. Boxlight develops, sells, and services its integrated solution suite including interactive displays, collaboration software, audio solutions, supporting accessories, and professional services. For more information about Boxlight and the Boxlight story, visit http://www.boxlight.com, https://www.clevertouch.com and https://www.gofrontrow.com.

Forward Looking Statements

This press release may contain information about Boxlight’s view of its future expectations, plans and prospects that constitute forward-looking statements, including the information regarding finalization of a waiver with the Company’s lender. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to: our ability to continue operating as a going concern; our ability to comply with certain covenants, minimum liquidity and borrowing base requirements under our existing credit agreement, or to obtain waivers of compliance; our ability to maintain a listing of our Class A common stock; changes in the sales of our display products; seasonality; changes in our working capital requirements and cash flow fluctuations; competition; our ability to enhance our products and to develop, introduce and sell new technologies and products at competitive prices and in a timely manner; our reliance on resellers and distributors; the success of our strategy to increase sales in the business and government market; changes in market saturation for our products; challenges growing our sales in foreign markets; our dependency on third-party suppliers; our ability to enter into and maintain strategic alliances with third parties; our ability to keep pace with technology; changes in the spending policies or budget priorities for government funding of schools, colleges, universities, other education providers or government agencies. Boxlight encourages you to review other factors that may affect its future results and performance in Boxlight’s filings with the Securities and Exchange Commission, including under the heading “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2023, as filed on March 14, 2024, and any updated to those risk factors in Boxlight’s subsequently filed Quarterly Reports on Form 10-Q. Given these factors, risks and uncertainties, we caution you not to place undue reliance on forward-looking statements. We expressly disclaim any obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by law.

Media & Investor Relations
[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Primary/Secondary Education

MEDIA:

byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination

New York, NY, Sept. 14, 2026 (GLOBE NEWSWIRE) — byNordic Acquisition Corporation (“BYNO” or the “Company”), a special purpose acquisition company, announced today that the Company has timely deposited into the Company’s trust account (the “Trust Account”), an aggregate of $8,850.20, in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from September 12, 2026 to October 12, 2026 (the “Extension”). The Extension is the second of up to twelve (12) one-month extensions permitted under the August 7, 2026 amendment to the Company’s Amended and Restated Certificate of Incorporation that allows the Company’s board of directors, in its sole discretion and without another stockholder vote, to elect to extend the termination date by one additional month each time up until August 12, 2027, or the closing of the Company’s initial business combination.

About byNordic Acquisition Corporation

byNordic Acquisition Corporation, led by Chief Executive Officer Michael Hermansson, is a special purpose acquisition company formed with the purpose of entering into a business combination with one or more businesses. While the Company may pursue an initial business combination with a company in any sector or geography, it intends to focus its search on high technology growth companies based in the northern part of Europe.

Forward Looking Statements

This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

byNordic Acquisition Corporation Contact:

Michael Hermansson
+46 707 294100
[email protected]



Cipher Digital, Fluidstack, and Anthropic Commit $10 Million to Repair and Expand Colorado City’s Water System

City Leaders Chose the Projects After July Storm Damage Cut Residents’ Water; Barber Lake Data Center Draws No Water from the City’s System

COLORADO CITY, Texas, Sept. 14, 2026 (GLOBE NEWSWIRE) — Cipher Digital Inc. (NASDAQ:CIFR), a leading developer and operator of industrial-scale data centers, Fluidstack Ltd., an American builder of AI infrastructure, and Anthropic, the AI research and development company behind Claude, today committed a combined $10 million in repairs and upgrades to Colorado City’s water system. The contribution will fund upgrades identified by Colorado City leaders to increase the availability and resilience of the city’s water system following this summer’s shortages. The companies will manage the funds in partnership with Colorado City leaders through the formation of the Colorado City Water Infrastructure Foundation, a newly established nonprofit organization funded exclusively by the companies to serve Colorado City.

Colorado City has faced chronic water outages due to aging infrastructure and severe weather. In July, storm damage at the city’s well pump station left residents without reliable water for days. Cipher Digital, Fluidstack, and Anthropic are stepping forward to help their new neighbors address this issue.

The Foundation will work in coordination with the Colorado City Council under the leadership of Mayor Ruben Hurt, working closely with City Manager Donna Madrid and the City’s contracted engineers. The City identified a slate of water infrastructure projects, including additional water storage capacity, replacing aging valves, and other water infrastructure needs that the companies have agreed to fund. The Barber Lake data center runs on its own on-site water supply and draws nothing from Colorado City’s system, so every gallon of capacity these projects add goes to the city.

“As Texas continues to grow, it is important that the companies helping drive that growth are also good neighbors and partners in our communities,” said Texas House Speaker Dustin Burrows. “This donation for Colorado City’s water infrastructure will strengthen the region’s water future while demonstrating a commitment to the Texans who call this community home. I want to thank the companies for their generosity and for investing in the long-term future of Colorado City and West Texas.”

“When we welcomed these companies to our community, they told us they would be good neighbors,” said Colorado City Mayor Ruben Hurt. “This $10 million contribution for critical repairs to our local water system demonstrates they meant every word.”

“Being a good neighbor means showing up for the issues that matter most to the communities where we operate, even when those issues predate us,” said Tyler Page, Cipher’s Chief Executive Officer. “In Colorado City, we wanted to invest directly in solutions that will benefit the community for years to come. We’re grateful to Speaker Burrows and local leaders for their partnership, and proud that Colorado City is home to one of our data centers.”

“Everywhere Fluidstack operates, we try to listen first and understand what the community actually needs,” said Kate Franko, Public Affairs Lead for Fluidstack. “This summer, our neighbors here had a problem. We asked if we could help, and we’re glad the answer was yes.”

“Communities that host AI infrastructure should be better off for it. Colorado City’s leaders identified what their water system needs, and we’re glad to help fund it,” said Ryan Wilson, Head of Economic Development for Anthropic.

Cipher built Barber Lake to meet the data center standards in Governor Greg Abbott’s directives to the Public Utility Commission of Texas and ERCOT. The facility’s use of water will have no impact on local drinking water sources or residential utility bills.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the Foundation’s planned activities and projects, the administration and deployment of committed funds, coordination with Colorado City and other stakeholders, anticipated community benefits, and Cipher’s business objectives. Actual results may differ materially due to changes in project selection or scope; required approvals; coordination with the City, engineers and other stakeholders; engineering, permitting, procurement, construction, cost or timing constraints; and whether completed projects achieve their anticipated benefits. Additional risks are described in the “Risk Factors” sections of Cipher’s Annual Report on Form 10-K for the year ended December 31, 2025, its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, and subsequent SEC filings. Forward-looking statements speak only as of the date made, and Cipher undertakes no obligation to update them except as required by law.

About Cipher

Cipher develops and operates industrial-scale data centers engineered for next-generation computing at the highest standards of innovation, precision, and excellence. The Company brings together deep expertise across power sourcing, construction, engineering, operations, real estate, and technology to deliver high-quality data centers purpose built for HPC workloads. By partnering with premier tenants, Cipher seeks to meet the growing demand for industrial-scale data center capacity and become a leading HPC development platform that is built for hyperscale. To learn more about Cipher, please visit cipherdigital.com.

About Fluidstack

Fluidstack is an American builder of AI infrastructure, deploying scaled compute at speed for leading AI labs, governments, and enterprises. From its growing base in Texas, Fluidstack builds with a commitment to transparency, local partnership, and environmental accountability. Learn more at fluidstack.io

About Anthropic

Anthropic is an AI research and development company that creates reliable, interpretable, and steerable AI systems. Anthropic’s flagship product is Claude, a large language model trusted by millions of users worldwide. Learn more about Anthropic and Claude at anthropic.com.

Cipher Contact:

Ryan Dicovitsky
Dukas Linden Public Relations
[email protected]

Fluidstack Contact:

Katie LePage
The Monument Group
[email protected]

Anthropic Contact:

[email protected]